CURITY PHARMA A.E.
COPYRIGHT, INTELLECTUAL PROPERTY & ACCEPTABLE USE NOTICE
Document ID: LEG-WEB-005
Version: 1.0
Effective Date: 06 July 2026
Review Date: 06 July 2028
Document Owner: Curity Pharma A.E.
1. Purpose
This Copyright, Intellectual Property & Acceptable Use Notice (“Notice”) establishes the conditions governing the use, reproduction, and protection of the content published on the Curity Pharma website.
This Notice supplements the:
- Terms of Use;
- Privacy Policy;
- Cookie Policy; and
- Medical & Regulatory Disclaimer.
In the event of any inconsistency, the Terms of Use shall prevail.
2. Ownership of Website Content
Unless expressly stated otherwise, all content published on this website is the exclusive property of CURITY PHARMA A.E. or is used under licence from the relevant rights holder.
This includes, without limitation:
- Company name and branding;
- Registered and unregistered trademarks;
- Logos;
- Trade names;
- Website design and layout;
- Text and written materials;
- Graphics and illustrations;
- Icons;
- Diagrams;
- Facility photographs;
- Greenhouse photographs;
- Laboratory photographs;
- Manufacturing facility photographs;
- Videos and animations;
- Scientific summaries prepared by Curity Pharma;
- Genetics and cultivar descriptions;
- Cultivation methodologies;
- Process descriptions;
- Technical documentation;
- Downloadable documents;
- Databases and compilations;
- Software and website functionality.
All intellectual property rights are reserved.
3. Copyright
All original works published on this website are protected under applicable copyright legislation and international copyright treaties.
No ownership rights are transferred through access to this website.
Except where expressly permitted by applicable law, no material may be reproduced without prior written permission from Curity Pharma.
4. Trademarks
The Curity Pharma name, logo and associated branding are proprietary trademarks or protected commercial identifiers.
Nothing contained on this website grants any licence or right to use any trademark without the prior written permission of Curity Pharma.
Third-party trademarks remain the property of their respective owners.
5. Permitted Use
Visitors may:
- browse the website;
- download publicly available documents for personal reference;
- print reasonable portions of publicly available information;
- cite publicly available content for educational, academic or journalistic purposes, provided that:
- appropriate attribution is given;
- the content is not altered in a misleading manner;
- no implication of endorsement by Curity Pharma is created.
Nothing in this Notice restricts rights that cannot legally be excluded under applicable copyright legislation.
6. Prohibited Use
Unless expressly authorised in writing, users may not:
- reproduce substantial portions of the website;
- commercially exploit website content;
- republish website content;
- modify or adapt content;
- create derivative works;
- distribute proprietary documents;
- remove copyright notices;
- remove trademarks;
- use photographs for commercial purposes;
- use Curity Pharma branding in advertising;
- falsely imply affiliation with Curity Pharma;
- use website content in a manner likely to damage the reputation of Curity Pharma.
7. Scientific Publications
Scientific publications referenced on this website remain the property of their respective publishers and copyright holders unless otherwise indicated.
References to scientific literature are provided solely for informational and educational purposes.
Where extracts are reproduced, they are used in accordance with applicable copyright legislation or with appropriate permission where required.
Users remain responsible for complying with copyright restrictions imposed by the original publisher.
8. Artificial Intelligence and Text & Data Mining
Curity Pharma expressly reserves all rights relating to the use of the content published on this website for text and data mining, artificial intelligence, machine learning, and similar automated processing technologies.
Except where mandatory legislation provides otherwise, no person or organisation may, without Curity Pharma’s prior written consent:
- systematically scrape or harvest website content;
- extract substantial portions of the website into databases;
- reproduce content for AI model training;
- use website content to develop or improve machine learning models;
- use website content in commercial retrieval-augmented generation (RAG) systems;
- incorporate proprietary content into datasets used by generative artificial intelligence systems;
- reproduce scientific summaries or proprietary technical material for automated processing.
For the purposes of Article 4 of Directive (EU) 2019/790 on Copyright in the Digital Single Market, Curity Pharma expressly reserves all rights relating to text and data mining of the content made available through this website.
Nothing in this section shall restrict lawful indexing by generally recognised internet search engines operating in accordance with accepted internet standards.
9. Automated Access
Users shall not:
- deploy bots that adversely affect website performance;
- conduct automated vulnerability scanning without prior authorisation;
- interfere with website security;
- attempt unauthorised access;
- overload website infrastructure;
- bypass security measures;
- harvest email addresses or personal information.
Reasonable automated access by recognised search engines for indexing purposes is permitted.
10. Requests for Permission
Requests to reproduce or reuse material published on this website should be submitted to:
Please include:
- the material requested;
- intended use;
- publication or organisation;
- expected audience;
- duration of use.
Permission may be granted or refused at Curity Pharma’s sole discretion.
11. Enforcement
Curity Pharma reserves the right to take any lawful action necessary to protect its intellectual property rights, including seeking injunctive relief, damages, or any other remedies available under applicable law.
Unauthorised use of website content may constitute infringement of copyright, trademark, database rights, or other intellectual property rights.
12. Changes to this Notice
Curity Pharma may revise this Notice from time to time to reflect:
- legislative developments;
- changes to website content;
- technological developments;
- changes in business operations.
The latest version will always be published on the website.
13. Governing Law
This Notice shall be governed by the laws of Greece.
Any disputes arising in connection with this Notice shall be subject to the exclusive jurisdiction of the competent courts of Athens, Greece.
14. Contact
CURITY PHARMA A.E.
20 Chelmou Street
15125 Marousi
Athens
Greece
GEMI: 148638001000
VAT: EL801081551
Telephone: +30 210 6390267
Email: [email protected]
Website: https://curitypharma.com